A former critic of FDA and Pharma will now oversee the regulation of costly and complicated biologics like vaccines, gene therapies, and blood supply.
New FDA Leadership Could Raise The Bar For Drug Approvals
Where Today's News Shapes Tomorrow
March 4, 2026
Headlines
